CLINICAL_TRIALS
trial_result
· 2013-08-01
Clinical Trial Update: Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 safety and efficacy study of JTT-851 in patients with Type 2 Diabetes Mellitus has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Akros Pharma Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED